Hematology & Oncology Doctors in Mountain Lakes, NJ Accepting Medicare

6 Hematology & Oncology doctors found. Showing 1 - 6

Christopher Michael Tully, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701    Fax: 973-316-1708

Dr. Muhammad R. Abbasi, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701    Fax: 973-316-1708

Naveed Jan, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701    Fax: 973-316-1708

Fazal Bari, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701    Fax: 973-316-1708

Jason Levitz, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701    Fax: 973-316-1708

Dr. Ruby Hanna, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701

News Archive

Lack of methyl groups in gene body may lead to emergence of cancer

Every cell in our body contains the complete DNA library. So-called methyl groups regulate that in body tissues only the genetic information is expressed that is indeed needed in this tissue.

African Life Assurance launches AIDS assurance policy in Zambia

African Life Assurance has launched an AIDS assurance policy in Zambia that will allow companies in the country to provide their employees living with HIV/AIDS access to affordable antiretroviral treatment for the rest of their lives, according to Zambia's Post, Xinhua/People's Daily reports.

Champions Oncology operating revenues increase to $7.1M for the year ended April 30, 2012

Champions Oncology, Inc., formerly Champions Biotechnology, Inc., engages in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the year ended April 30, 2012.

Brachyury variation may increase risk of chordoma

A genetic variation possessed by 40% of the population is associated with a five-fold increase in risk for developing chordoma, a cancer that strikes the bones of the skull and spine.

New diagnostic system describes symptoms using the image of patient's tongue

Physicians often ask their patients to "Please stick out your tongue". The tongue can betray signs of illness, which combined with other symptoms such as a cough, fever, presence of jaundice, headache or bowel habits, can help the physician offer a diagnosis. For people in remote areas who do not have ready access to a physician, a new diagnostic system is reported in the International Journal of Biomedical Engineering and Technology that works to combine the soft inputs of described symptoms with a digital analysis of an image of the patient's tongue.

Read more Medical News

› Verified 1 days ago